Concepedia

Irmina Diala

ID

12

Publications

770

Citations

11

H-Index

2013

Active since

Affiliations

Puma Biotechnology (United States)(Current)

The University of Texas MD Anderson Cancer Center

Virginia Commonwealth University

Irmina Diala is an author at Puma Biotechnology (United States) specializing in medicine, cancer research, and cancer cell biology.

Top concepts

Publications per year

2013–2021

12

Publications

12

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers

Bob T. Li, Flavia Michelini, Sandra Misale et al. · Cancer Discovery · 2020 · 274 citations · Full text

Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis

Aadya Nagpal, Richard P. Redvers, Xiawei Ling et al. · Breast Cancer Research · 2019 · 148 citations · Full text

Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway

Irmina Diala, Nicole Wagner, Frédérique Magdinier et al. · EMBO Reports · 2013 · 80 citations · Full text

, , +9

Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors

Neil T. Conlon, Jeffrey J. Kooijman, Suzanne J.C. van Gerwen et al. · British Journal of Cancer · 2021 · 68 citations · Full text

Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer

Ming Zhao, Stephen M. Scott, Kurt W. Evans et al. · Clinical Cancer Research · 2021 · 58 citations · Full text

Rows per page

1–5 of 12